Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.
ProMed BioSciences has raised $1.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
ProMed BioSciences's investors include Kinisis Ventures, Asbis.
ProMed BioSciences is headquartered in Limassol, Cyprus.
Promed Bioscience is a provider of manufacture and supply of highly purified research and medical grade collagen from animal tissue.
ProMed BioSciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ProMed BioSciences — Funding & Investors." VCBacked, November 25, 2025, https://www.vcbacked.co/company/promed-biosciences. Accessed August 14, 2026.
VCBacked. (2025). ProMed BioSciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/promed-biosciences
{{cite web |title=ProMed BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/promed-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated